Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC

NEW YORK (TheStreet) -- Teva Pharmaceuticals (TEVA) stock rating was increased to "buy" from "hold" at HSBC (HSBC) Monday morning.

The firm upped its price target for the Israeli pharmaceutical company to $65 from $61, based on the Allergan (AGN) Generics deal that's expected to close any day now, TheFly reports.

Teva's deal with Allergen would also lift some of the burden on the stock generated by Copaxone, the firm noted.

Shares of Teva are down 0.29% to $54.06 in afternoon trading on Monday.

The...


More